HLA-DRB1 and Epstein-Barr virus infection: Thus, EBV specific immune control based on HLA-DRB1*1501 restricted CD4+ T cells could be less efficient in controlling EBV infection and stimulate autoimmunity in part via the resulting elevated levels of EBV transformed B cells.